Further characterization of the target of a potential aptamer biomarker for pancreatic cancer: Cyclophilin B and its posttranslational modifications

Nucleic Acid Therapeutics

Volumn 23, Issue 6, 2013, Pages 435-442

  Ray, Partha ^a   Sullenger, Bruce A ^a   White, Rebekah R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; BIOLOGICAL MARKER; CYCLOPHILIN B;

ANIMAL CELL; ARTICLE; BACTERIUM; CANCER PATIENT; CELL LINE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; SERUM; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

APTAMERS, NUCLEOTIDE; CYCLOPHILINS; HEK293 CELLS; HUMANS; PANCREATIC NEOPLASMS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84890389407     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2013.0439     Document Type: Article

References (35)

1. ARIF, M., SENAPATI, P., SHANDILYA, J., and KUNDU, T.K. (2010). Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochim. Biophys. Acta 1799, 702-716
2. BASKA, K.M., MANANDHAR, G., FENG, D., AGCA, Y., TENGOWSKI, M.W., SUTOVSKY, M., YI, Y.J., and SUTOVSKY, P. (2008). Mechanism of extracellular ubiquitination in the mammalian epididymis. J. Cell Physiol. 215, 684-696
3. BLOW, N. (2007). Antibodies: The generation game. Nature 447, 741-744
4. CONRAD, R., KERANEN, L.M., ELLINGTON, A.D., and NEWTON, A.C. (1994). Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 269, 32051-32054
5. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822
6. HELD, D.M., KISSEL, J.D., THACKER, S.J., MICHALOWSKI, D., SARAN, D., JI, J., HARDY, R.W., ROSSI, J.J., and BURKE, D.H. (2007). Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers. J. Virol. 81, 5375-5384
7. HUANGFU, W.C., QIAN, J., LIU, C., RUI, H., and FUCHS, S.Y. (2010). Melanoma cell-secreted soluble factor that stimulates ubiquitination and degradation of the interferon alpha receptor and attenuates its signaling. Pigment Cell Melanoma Res. 23, 838-840
8. ISHIZAKI, J., NEVINS, J.R., and SULLENGER, B.A. (1996). Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med. 2, 1386-1389
9. JENISON, R.D., GILL, S.C., PARDI, A., and POLISKY, B. (1994). High-resolution molecular discrimination by RNA. Science 263, 1425-1429
10. JIN, H., and ZANGAR, R.C. (2009). Protein modifications as potential biomarkers in breast cancer. Biomark Insights 4, 191-200
11. KAZANECKI, C.C., KOWALSKI, A.J., DING, T., RITTLING, S.R., and DENHARDT, D.T. (2007). Characterization of antiosteopontin monoclonal antibodies: Binding sensitivity to post-Translational modifications. J. Cell Biochem. 102, 925-935
12. KELLER, A., NESVIZHSKII, A.I., KOLKER, E., and AEBERSOLD, R. (2002). Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
13. KIM, W., BENNETT, E.J., HUTTLIN, E.L., GUO, A., LI, J., POSSEMATO, A., SOWA, M.E., RAD, R., RUSH, J., COMB, M.J., et al. (2011). Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340
14. KOMANDER, D. (2009). The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953
15. LAMMERS, M., NEUMANN, H., CHIN, J.W., and JAMES, L.C. (2010). Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization. Nat. Chem. Biol. 6, 331-337
16. MCDONALD, W.H., and YATES, J.R., 3RD (2002). Shotgun proteomics and biomarker discovery. Dis. Markers 18, 99-105
17. NESVIZHSKII, A.I., KELLER, A., KOLKER, E., and AEBERSOLD, R. (2003). A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
18. RAY, P., RIALON-GUEVARA, K.L., VERAS, E., SULLENGER, B.A., and WHITE, R.R. (2012). Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker. J. Clin. Invest. 122, 1734-1741
19. RECHSTEINER, M. (1987). Ubiquitin-mediated pathways for intracellular proteolysis. Annu. Rev. Cell Biol. 3, 1-30
20. SHAHBAZIAN, M.D., and GRUNSTEIN, M. (2007). Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100
21. SINCHAIKUL, S., HONGSACHART, P., SRIYAM, S., TANTIPAIBOONWONG, P., PHUTRAKUL, S., and CHEN, S.T. (2008). Current proteomic analysis and post-Translational modifications of biomarkers in human lung cancer materials. Chang Gung Med. J. 31, 417-430
22. STRIETER, E.R., and KORASICK, D.A. (2012). Unraveling the complexity of ubiquitin signaling. ACS Chem. Biol. 7, 52-63
23. STRUHL, K. (1998). Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606
24. SUNDARARAJAN, N., MAO, D., CHAN, S., KOO, T.W., SU, X., SUN, L., ZHANG, J., SUNG, K.B., YAMAKAWA, M., GAFKEN, P.R., et al. (2006). Ultrasensitive detection and characterization of posttranslational modifications using surfaceenhanced Raman spectroscopy. Anal. Chem. 78, 3543-3550
25. TAUSSIG, M.J., STOEVESANDT, O., BORREBAECK, C.A., BRADBURY, A.R., CAHILL, D., CAMBILLAU, C., DE DARUVAR, A., DUBEL, S., EICHLER, J., FRANK, R., et al. (2007). ProteomeBinders: Planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 4, 13-17
26. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510
27. UHLEN, M. (2007). Mapping the human proteome using antibodies. Mol. Cell Proteomics 6, 1455-1456
28. WAGNER, S.A., BELI, P., WEINERT, B.T., NIELSEN, M.L., COX, J., MANN, M., and CHOUDHARY, C. (2011). A proteomewide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell Proteomics 10, M111 013284
29. WEINERT, B.T., IESMANTAVICIUS, V., WAGNER, S.A., SCHOLZ, C., GUMMESSON, B., BELI, P., NYSTROM, T., and CHOUDHARY, C. (2013). Acetyl-phosphate is a critical determinant of lysine acetylation in E. coli. Mol. Cell 51, 265-272
30. WILKINSON, K.D. (1987). Protein ubiquitination: A regulatory post-Translational modification. Anticancer Drug Des. 2, 211-229
31. WILLIAMS, B.A., LIN, L., LINDSAY, S.M., and CHAPUT, J.C. (2009). Evolution of a histone H4-K16 acetyl-specific DNA aptamer. J. Am. Chem. Soc. 131, 6330-6331
32. YU, B.J., KIM, J.A., MOON, J.H., RYU, S.E., and PAN, J.G. (2008). The diversity of lysine-Acetylated proteins in Escherichia coli. J. Microbiol. Biotechnol. 18, 1529-1536
33. ZHANG, K., ZHENG, S., YANG, J.S., CHEN, Y., and CHENG, Z. (2013). Comprehensive profiling of protein lysine acetylation in Escherichia coli. J. Proteome Res. 12, 844-851
34. ZHAO, J., XIN, M., WANG, T., ZHANG, Y., and DENG, X. (2009). Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation. Mol. Cancer Res. 7, 1954-1961
35. ZICHEL, R., CHEARWAE, W., PANDEY, G.S., GOLDING, B., and SAUNA, Z.E. (2012). Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins. PLoS One 7, e31948